As generative AI makes production faster and cheaper, ten global creators argue that value is shifting toward taste, systems, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Upstream stock rises 26.5% above IPO price Drug developer valued at $1.1 bln at open Healthcare sector leads US IPO market in 2024 Oct 11 (Reuters) - Shares of Upstream Bio (UPB.O), opens new tab ...
Upstream Bio completed Phase 2 trial enrollment for verekitug and raised $293 million in an IPO, funding operations through 2027. Upstream Bio, Inc. announced the completion of patient enrollment in ...
– Positive top-line results from VIBRANT Phase 2 trial of verekitug in CRSwNP reported in September showed statistically significant and clinically meaningful effects on primary and key secondary ...
WALTHAM, Mass., June 08, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results